Interestingly, IL-17−/− mice did not develop lupus after pristane injection, whereas wild-type mice developed lupus (33), as evidenced by increased autoantibody production and the development of glomerulonephritis. The gene discussed is IL17A; the disease is systemic lupus erythematosus.